Changes in Lipoprotein Particle Number With Ezetimibe/Simvastatin Coadministered With Extended‐Release Niacin in Hyperlipidemic Patients

BACKGROUND: Combination therapy with ezetimibe/simvastatin (E/S) and extended‐release niacin (N) has been reported to be safe and efficacious in concomitantly reducing low‐density lipoprotein cholesterol and increasing high‐density lipoprotein cholesterol in hyperlipidemic patients at high risk for...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Ngoc‐Anh, Jin, Ran, Tomassini, Joanne E., Tershakovec, Andrew M., Neff, David R., Wilson, Peter W.F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828803/
https://www.ncbi.nlm.nih.gov/pubmed/23926117
http://dx.doi.org/10.1161/JAHA.113.000037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828803/
https://www.ncbi.nlm.nih.gov/pubmed/23926117
http://dx.doi.org/10.1161/JAHA.113.000037

Ejemplares similares